Cytek Biosciences to Host Inaugural Analyst and Investor Day
June 01, 2022 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., June 01, 2022 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB) announced today that it will host its inaugural Analyst and Investor Day...
Cytek® Biosciences Receives CE Marking for Series of cFluor® Reagents, TBNK Kit
May 24, 2022 10:00 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., May 24, 2022 (GLOBE NEWSWIRE) -- Clinical flow cytometry laboratories based in Europe can now purchase Cytek cFluor® CE-IVD-certified reagents for their use. Cytek Biosciences, Inc....
Cytek Biosciences Reports First Quarter 2022 Financial Results
May 11, 2022 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., May 11, 2022 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB) today reported financial results for the first quarter ended March 31,...
Cytek Biosciences to Report First Quarter Financial Results on May 11, 2022
April 28, 2022 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the first quarter...
Cytek Biosciences Appoints Todd Garland Chief Commercial Officer
April 28, 2022 08:00 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the appointment of Todd Garland as Chief...
Cytek Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results
February 23, 2022 16:05 ET
|
Cytek Biosciences, Inc.
2021 Revenue Increased 38% Compared to Prior Year FREMONT, Calif., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB) today reported...
Cytek to Participate in the 42nd Annual Cowen Health Care Conference
February 16, 2022 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Feb. 16, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced the company will be participating virtually in the...
Cytek Biosciences to Report Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022
February 11, 2022 08:00 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the fourth quarter...
Cytek® Biosciences Expands Fremont Headquarters, Tripling Its Manufacturing Capacity
January 05, 2022 10:00 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that it has opened a new facility in Fremont,...
Cytek® Biosciences Marks Milestone Achievement with Shipment of 1000th Cell Analysis System
November 17, 2021 10:00 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced a significant milestone: the company has shipped...